Dasatinib
Dasatinib (Sprycel) appears in one listed bottle, the named brand. This antineoplastic medicine has recorded uses for chronic myeloid leukaemia and acute lymphoblastic leukaemia. The product’s strength, formulation and directions define its place within cancer treatment. Listed products differ in ingredient profile, form, strength, and pack size.
How does dasatinib work?
Dasatinib blocks selected tyrosine kinases, including BCR-ABL, that can drive abnormal blood-cell growth. Sprycel addresses Chronic Myeloid Leukaemia and Acute Lymphoblastic Leukaemia within Oncology Support.
Important safety information for Dasatinib
Information about Dasatinib on this page is an educational overview, not medical advice. Products can differ in formulation, strength, and directions, and this content does not authorise clinical application or unsupervised use. Review the labelling for each product and speak with a healthcare professional whenever clinical judgement is needed. Product-specific contraindications, interactions, and reactions should be checked in the product labelling and verified clinical sources.